| ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| L01XG02 | B | Carfilzomib - 60mg | 8499 | 150015/1 | KYPROLIS | 60mg | 1 | Injectable powder for solution | Infusion | Mersaco | Amgen Technology (Ireland) Unlimited Company (ADL) | Ireland | 96,642,005 L.L | 2.44 | E2 | Onyx Pharmaceuticals Inc | USA | 6/3/2026 |
| ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| L01XG02 | G | Carfilzomib - 60mg | 12596 | 55626/1 | CARFILU | 60mg | 1 | Injectable powder for solution | Infusion | Levant Pulse SARL | Manufactured by Qilu Pharmaceutical (Hainan) Co Ltd, China Packed by Alfa Laboratoires S.A.L. | Lebanon | 58,470,568 L.L | 10.71 | E1 | Alfa Laboratoires S.A.L. | Lebanon | 6/3/2026 | |
| L01XG02 | B | Carfilzomib - 60mg | 8499/388 | 150015/1 | KYPROLIS | 60mg | 1 | Injectable powder for solution | Infusion | Mersaco | Amgen Technology (Ireland) Unlimited Company (ADL) | Ireland | L.L | 2.44 | E2 | Onyx Pharmaceuticals Inc | USA | 6/3/2026 |
